The Canadian medical agency tasked with tracking and regulating the use and production of cannabis in the country announced new numbers on Monday (July 9) in terms of medical patients of the drug.

As part of the market information Health Canada tracks and publishes for cannabis, the agency now offers data on a monthly basis for its fiscal quarters, with the most recent one being January to March.


Based on the data, patient registration under the Access to Cannabis for Medical Purposes Regulations (ACMPR) program has continued to increase. At the end of March 2018, the fiscal fourth quarter for Health Canada, data showed a total number of patient registrations of 296,702.

According to cannabis analyst with 420 Investor Alan Brochstein, the growth last quarter represents quarterly growth of 10.1 percent and annual growth of 79.9 percent.

Brochstein called the increment in legal cannabis patients “robust” but highlighted it was the slowest quarterly growth since the origin of the program. He said these figures represent a maturation of the medical cannabis program and “perhaps some hesitancy among potential patients who will just wait for legalization.

Cannabis oils continue market dominance in legal medical landscape

The federal agency also offered an update on the amount of legal cannabis patients had access to during the most recent fiscal quarter.

Cannabis oils continued its growth path while dried flower remained steady with 6,610 kilograms sold during the fourth fiscal quarter. Oils amounted to 10,326 kilograms, an 11 percent increase from the previous quarter according to Brochstein.

During the fiscal 2017-2018 year, Health Canada reported 33,463 kilograms of cannabis oil sold to patients, while the amount of dried flower sold during the fiscal year was 24,753 kilograms.

Licensed producers (LP) of cannabis in Canada reported a total saved inventory worth 44,179 kilograms of dried cannabis and 15,727 litres at the end of March.

Investor takeaway

Despite the limited offerings of legal cannabis product for consumers at the time of this data, investors are able to see the demand for cannabis oils surpases dried flower in the medical space as consumers seek more variety for treatments.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact ir@hillstreetbevco.com, or

Keep reading... Show less